[IMATINIB INDUCED EDEMA].
Harefuah
; 163(6): 397, 2024 Jun.
Article
en He
| MEDLINE
| ID: mdl-38884296
ABSTRACT
INTRODUCTION:
Imatinib is a tyrosine kinase inhibitor and is used for the treatment of chronic myeloid leukemia (CML) since 2002. We present a patient who suffered from fluid retention and periorbital edema secondary to this drug.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Leucemia Mielógena Crónica BCR-ABL Positiva
/
Inhibidores de Proteínas Quinasas
/
Edema
/
Mesilato de Imatinib
/
Antineoplásicos
Límite:
Female
/
Humans
/
Male
/
Middle aged
Idioma:
He
Revista:
Harefuah
Año:
2024
Tipo del documento:
Article